Considering that IDH2 plays an important role in regulating mitochondrial metabolism and redox status [9,18], which could in turn affect cellular response to drug treatment, we further evaluated the relationship between IDH2-mediated metabolic changes and drug sensitivity in lung cancer cells to decipher the underlying mechanisms. The gene discussed is IDH2; the disease is lung carcinoma.